Benzinga | Dec 10, 2021 01:42PM EST

Spruce Biosciences Wins Patent Trial Related To Tildacerfont Patent As Post Grant Review Filed By Neurocrine Biosciences Was Not Instituted

https://t.co/NEHhmM5hV9